Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in hematologic disease treatments, has announced its participation in four major upcoming investor conferences in March 2025.

The company will deliver presentations at:

• TD Cowen 45th Annual Health Care Conference in Boston (March 5th, 9:10 a.m. ET)
• Leerink Global Healthcare Conference in Miami (March 10th, 2:20 p.m. ET)
• Barclays 27th Annual Global Healthcare Conference in Miami (March 13th, 9:30 a.m. ET)
• Jefferies Biotech on the Beach Summit in Miami (March 11th)

Live webcasts of the presentations and fireside chats will be accessible through Disc Medicine's investor relations website, with archived replays available post-event.

WATERTOWN, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at three upcoming investor conferences:

• TD Cowen 45^th Annual Health Care Conference (Boston, MA): Corporate presentation on Wednesday, March 5^th at 9:10 a.m. ET.
  
• Leerink Global Healthcare Conference (Miami, FL): Fireside chat on Monday, March 10^th at 2:20 p.m. ET.

• Barclays 27^th Annual Global Healthcare Conference (Miami, FL): Fireside chat on Thursday, March 13^th at 9:30 a.m. ET.
  

Disc management will be participating in investor meetings during each of the above conferences, as well as the Jefferies Biotech on the Beach Summit in Miami, FL. The Jefferies meetings take place on Tuesday, March 11^th.

Live webcasts of the corporate presentation and fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com

FAQ

When is Disc Medicine (IRON) presenting at the TD Cowen Healthcare Conference in 2025?

Disc Medicine will present at the TD Cowen Conference on March 5th, 2025, at 9:10 a.m. ET in Boston.

Which investor conferences will Disc Medicine (IRON) attend in March 2025?

Disc Medicine will attend four conferences: TD Cowen, Leerink Global Healthcare, Barclays Global Healthcare, and Jefferies Biotech on the Beach Summit.

How can investors access Disc Medicine's (IRON) conference presentations?

Investors can access live webcasts and archived replays through Disc Medicine's investor relations website at ir.discmedicine.com.

What is Disc Medicine's (IRON) focus in the healthcare sector?

Disc Medicine is a clinical-stage biopharmaceutical company focused on developing novel treatments for serious hematologic diseases.

Where will Disc Medicine (IRON) host its Miami conference presentations in March 2025?

In Miami, Disc Medicine will present at the Leerink Conference (March 10th), Jefferies Summit (March 11th), and Barclays Conference (March 13th).